Mucormycosis is an aggressive mold infection that mostly attacks patients with certain underlying conditions such as diabetes, hematological malignancies, neutropenia, major solid organ transplantation, or hematopoietic stem cell transplantation [1,2]. Given the increased prevalence of predisposing conditions in the modern era including Coronavirus disease 2019 (COVID-19) [3,4], the incidence of mucormycosis has increased as well [5–8]. Despite the advances in modern medicine, rhino-orbito-cerebral mucormycosis (ROCM) still has excessively high mortality rates.
